Novo Nordisk Builds Its World’s Tallest Elevated Stereo Warehouse in TEDA

Recently, Novo Nordisk (China) Pharmaceutical Co., Ltd. started building its tallest elevated stereoscopic warehouse in its TEDA-based Tianjin Plant. Involving a total investment of 500 million yuan, the new warehouse is key to Novo Nordisk’s capital increase and capacity expansion in Tianjin. Comprising both normal-temperature storage and cold storage with automated logistics system, the new warehouse will be put into service at the end of 2024.

The Tianjin Production Plant is one of Novo Nordisk’s strategic global production bases, and is also its only global supplier of insulin durable injection devices and the largest insulin formulation and filling production site. “The company will continue to deepen its full industry chain layout and is committed to continuously introducing more innovative drugs to China and localizing production in Tianjin. ” Nielsen, Novo Nordisk’s global corporate vice president and president of Tianjin Production Plant, said.